ABBV-744 in clinical trials for non-small cell lung cancer (NSCLC) Options
Participant eaten grapefruit or grapefruit products and solutions within three days just before the primary dose of study drug.There might be increased treatment burden for members Within this trial in comparison to their regular of treatment. Participants will go to regular visits over the study in a clinic or clinic.Expanded access is a way by wh